Meta-analysis of primary care delivered buprenorphine treatment retention outcomes

HIV clinic-based buprenorphine plus naloxone versus referral for methadone maintenance therapy for treatment of opioid use disorder in HIV clinics in Vietnam (BRAVO): an open-label, randomised, non-inferiority trial

(2021) P Todd Korthuis et al.   Lancet HIV

Disparities in Opioid Overdose Death Trends by Race/Ethnicity, 2018–2019, From the HEALing Communities Study

(2021) Marc R. Larochelle et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

The rise in non‐fatal and fatal overdoses involving stimulants with and without opioids in the United States

(2020) Brooke Hoots et al.   ADDICTION

Retention of Patients With Multiple Vulnerabilities in a Federally Qualified Health Center Buprenorphine Program: Pennsylvania, 2017–2018

(2020) Lara Carson Weinstein et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Buprenorphine Treatment By Primary Care Providers, Psychiatrists, Addiction Specialists, And Others

(2020) Mark Olfson et al.   HEALTH AFFAIRS

Primary Care Providers And Specialists Deliver Comparable Buprenorphine Treatment Quality

(2020) Alex K. Gertner et al.   HEALTH AFFAIRS

Vital Signs: Characteristics of Drug Overdose Deaths Involving Opioids and Stimulants — 24 States and the District of Columbia, January–June 2019

(2020) Julie O’Donnell et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants — United States, 2015–2016

(2018) Puja Seth et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Multicomorbidity of chronic diseases and substance use disorders and their association with hospitalization: Results from electronic health records data

(2018) Li-Tzy Wu et al.   DRUG AND ALCOHOL DEPENDENCE

Integration of Buprenorphine Treatment with Primary Care: Comparative Effectiveness on Retention, Utilization, and Cost

(2018) Yea-Jen Hsu et al.   Population Health Management

Recent incarceration and buprenorphine maintenance treatment outcomes among human immunodeficiency virus–positive patients

(2016) Daniel P. Riggins et al.   Substance Abuse

National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment

(2015) Christopher M. Jones et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Buprenorphine Maintenance Treatment Retention Improves Nationally Recommended Preventive Primary Care Screenings when Integrated into Urban Federally Qualified Health Centers

(2014) Marwan S. Haddad et al.   JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE

A Buprenorphine Education and Training Program for Primary Care Residents: Implementation and Evaluation

(2012) Hillary V. Kunins et al.   Substance Abuse

Collaborative Care of Opioid-Addicted Patients in Primary Care Using Buprenorphine

(2011) Daniel P. Alford et al.   ARCHIVES OF INTERNAL MEDICINE

Unobserved versus observed office buprenorphine/naloxone induction: A pilot randomized clinical trial

(2010) Erik W. Gunderson et al.   ADDICTIVE BEHAVIORS

Conducting a best evidence systematic review. Part 1: From idea to data coding. BEME Guide No. 13

(2010) Marilyn Hammick et al.   MEDICAL TEACHER

Home Buprenorphine/Naloxone Induction in Primary Care

(2008) Joshua D. Lee et al.   JOURNAL OF GENERAL INTERNAL MEDICINE